Cabazitaxel
| Dosage Form | Concentrate for solution for infusion |
| Strength | 10 mg/ml |
| Strength per Unit | 45 mg/4.5 ml, 50 mg/5 ml, 60 mg/6 ml |
| ATC Code | L01CD04 |
| Drug Class | Antineoplastic agents, taxanes |
| Indication | Cabzitaxel EVER Pharma in combination with prednisone or prednisolone is indicated for the treatment of adult patients with metastatic castration resistant prostate cancer previously treated with a docetaxel-containing regimen. |
| CytoWrap® | Vials may be sheathed in a protective sleeve. |
Cabazitaxel EVER Pharma is a prescription medication. Information for healthcare professionals only.
See the Summary of Product Characteristics for full information about the medication.